# Grok 4.7 / bio-d01

Original final answer, shared by both scoring rounds.

The existing single-substrate, 30-minute coupled endpoint cannot be interpreted as target inhibition. Run a pre-specified four-module study on the purified enzymes: enzyme-free optical/fluorophore interference, reporter-enzyme-only activity, an orthogonal non-fluorescence readout of target product, and—only if a target effect remains—substrate-varied initial-rate tests of competitive versus other inhibition modes. Attribute the signal loss only after each upstream contribution is measured and subtracted or excluded.

## Concepts and how they relate

The observed quantity is not target activity. In this coupled assay the target converts substrate to an intermediate; a second enzyme acts on that intermediate and a fluorophore is detected (D2). Observed fluorescence is the product of four separable factors:

- target catalytic rate, which depends on active target, substrate, and any inhibitor
- coupling rate, which depends on active reporter enzyme and intermediate
- fluorophore yield per coupling event
- optical transmission at excitation and emission, including inner-filter absorption and quenching

Target inhibition acts on the first factor. Substrate competition, read here as competitive interaction at the target with respect to substrate, is a substrate-concentration-conditional subset of target inhibition, not a reporter mechanism. It is distinguished from noncompetitive, uncompetitive, tight-binding, or time-dependent target inhibition only after optical and reporter contributions are removed. Chemical destruction or sequestration of substrate is a separate, non-catalytic alternative and is tested by substrate preincubation without enzyme.

Reporter-system interference acts on the coupling enzyme, fluorophore yield, or optical transmission. D3 makes transmission the leading non-biochemical suspect, but it does not prove that absorption is the only, or even the dominant, cause. A compound can absorb and also inhibit one or both enzymes. The modules below estimate each term rather than assuming mutual exclusivity.

D1 makes the historical result non-diagnostic: one substrate concentration cannot separate competitive from noncompetitive effects, and a 30-minute endpoint does not establish that the rate was initial, that the coupler was in excess, or that substrate and fluorophore remained in their linear ranges.

## Evidence → inference → conclusion

1. D1 records one substrate concentration and one 30-minute endpoint. Inference: both a true decrease in initial rate and late-time artifacts (substrate depletion, coupler exhaustion, enzyme inactivation, product back-reaction, time-dependent onset) can lower that endpoint by the same amount. Conclusion: do not fit Ki or name a mode from the existing point; collect progress curves and vary substrate only after the detection path is cleared.

2. D2 states that product detection uses a second enzyme and a fluorophore. Inference: any loss of target activity, reporter activity, fluorophore brightness, or light transmission is observationally equivalent at the endpoint. Conclusion: run target and reporter reactions separately, and include an enzyme-free fluorophore arm.

3. D3 states that the compound absorbs near the excitation wavelength. Inference: an inner-filter effect is physically plausible and would lower fluorescence without either enzyme being inhibited. Conclusion: the first experimental branch is quantitative optical calibration in the same buffer, path, and reader geometry, not another coupled endpoint.

4. Purified target and reporter enzymes are available. Inference: each catalyst can be omitted, heat-inactivated after a calibrated kill step, or replaced by its product. Conclusion: the three named explanations are separable with these reagents; no new protein production is required for the primary decision.

What would change the recommendation: if a qualified orthogonal product assay cannot be built, stop at “not specific for the target” and do not claim target inhibition. If absorption at both excitation and emission is negligible across the soluble concentration range and an enzyme-free fluorophore spike is unaffected, drop the optical branch and proceed to the enzyme modules. If the original effect occurs only above the kinetic solubility limit, treat precipitation as the leading explanation until a fully soluble condition reproduces it.

## Alternatives the design must not collapse

- Optical inner filter or quenching, with or without turbidity/scattering that inflates apparent absorbance (D3 does not distinguish absorption from scatter).
- Reporter-enzyme inhibition, reporter-substrate competition, or consumption of a coupling cofactor.
- Target inhibition that is competitive, noncompetitive, uncompetitive, mixed, tight-binding, or slow-onset.
- Non-specific enzyme inactivation (aggregation, covalent modification, pH or solvent shift).
- Chemical loss of the target substrate before catalysis.
- A mixed mechanism in which more than one of the above is real.

Binding methods (thermal shift, SPR, ITC) are optional adjuncts if instruments exist. They do not replace activity measurements: binding to the target does not prove the fluorescence loss was on-target, and lack of binding does not prove an optical artifact if the interaction is weak or covalent.

## Assumptions and unreported parameters

Assumptions, labeled as such: the researcher can obtain the authentic target product or generate it enzymatically as a calibrant; assay buffer, vehicle, and the nominal compound concentration of the original observation are known; both enzymes retain activity in that buffer. Not assumed: Km, kcat, wavelengths, path length, extinction coefficients, solubility, coupling excess, linear time window, or that the historical 30-minute point was valid.

Do not import numbers from an unrelated method. Calibrate each unknown as follows before the decision runs.

- Wavelengths and path: record compound absorbance and the assay excitation/emission bands on the same reader or a matched path. “Near” (D3) is not “at”.
- Linear fluorophore range: titrate authentic fluorophore, or coupler-generated fluorophore, in assay buffer. Accept only the interval where signal versus concentration is linear within a pre-specified tolerance (recommend 5% deviation from the low-concentration slope; verify in the pilot).
- Inner-filter factor: in enzyme-free buffer, measure fluorescence of a fixed in-range fluorophore concentration across a compound concentration series, and measure A at excitation and emission. Treat any textbook correction of the form F_corr = F_obs × 10^((A_ex + A_em)/2) as a model to be tested, not as a fact. Accept it only if it predicts the empirical attenuation within the pre-specified tolerance for this plate or cuvette geometry. Otherwise use the empirical attenuation factor from the matched fluorophore spike.
- Kinetic solubility and scatter: prepare the compound in assay buffer at the original concentration and above. Compare absorbance before and after centrifugation or low-binding filtration. A drop in apparent A, or visible turbidity, means the soluble concentration is unknown until a filtrate is quantified by a calibrated absorbance or LC standard curve of the compound.
- Target and reporter kinetic constants: for each enzyme, measure initial rates versus its own substrate at fixed enzyme, fit Km and Vmax by nonlinear regression, and repeat on at least two days. Use those estimates only to choose subsequent concentrations.
- Initial-rate window: from progress curves without compound, define t_linear as the longest time at which the slope remains within a pre-specified tolerance of the earliest slope (recommend 10%, confirmed in the pilot) and fractional substrate conversion stays low. The historical 30 minutes is a sampling time to record, not the analysis time, unless it falls inside t_linear.
- Coupler excess: titrate reporter enzyme at fixed target and substrate until the observed target rate plateaus. Use a coupler level on that plateau, with extra margin determined by the pilot, so reporter inhibition of modest potency cannot masquerade as target inhibition in the coupled format. Still run the reporter-only module; excess coupler does not excuse skipping it.
- Vehicle tolerance: titrate vehicle to the highest volume fraction used. Accept a fraction only if rate and fluorescence blank change by less than the same pre-specified tolerance.
- Inactivation control: establish a heat or other kill condition that removes catalytic activity of each enzyme and does not itself change the optical blank.

Unknown sample size is not invented here. From a pilot of independent mixtures, estimate the SD of the rate or of percent signal remaining. Set n so that the confidence interval for the pre-specified equivalence margin (below) excludes trivial noise. If the pilot SD is unstable across days, the day is a blocking factor and n must count days, not wells.

## Operational protocol

### 1. Preparation and quality checks

Lock the decision rules, equivalence margins, and analysis code before viewing mechanism outcomes. Prepare independent stocks: target enzyme, reporter enzyme, target substrate, reporter substrate or intermediate, fluorophore or fluorophore precursor, vehicle, and compound. Use the calibrated vehicle fraction. Confirm both enzymes are active by a short progress curve the same day. Confirm blanks: buffer, vehicle, compound without fluorophore, and enzymes without substrate. Reject the day if vehicle-only rate has drifted beyond the pilot tolerance or if compound scatter fails the solubility check at the concentration being interpreted. Pre-define a single primary concentration equal to the original observation, plus a concentration series spanning no detectable effect up to the highest fully soluble concentration.

### 2. Independent units

The experimental unit is an independently prepared reaction mixture: separate enzyme dilution and separate compound dilution, not adjacent wells filled from one master mix. Technical wells from one mix estimate pipetting error only. Block by day and by enzyme thaw. If only one enzyme lot exists, conclusions apply to that lot; contaminant-mediated effects remain possible. Plan at least two independent days after the pilot for any call that will be reported as a mechanism.

### 3. Allocation and blinding

Randomize well or cuvette position, concentration order, and module order with a list generated before plating. Code compound and vehicle so the person who acquires spectra and fits curves does not see hypothesis labels. Unblind only after the primary fits and the decision-rule output are locked. Do not rearrange wells after seeing controls; plate-position artifacts are handled by randomization and by including edge wells only if the pilot showed no positional gradient.

### 4. Intervention and sampling

Apply the same buffer, temperature, vehicle, and nominal compound concentrations in every module. Include a no-compound vehicle arm matched in every other component. Read continuously if the instrument allows; otherwise sample at t = 0, at several times inside the calibrated t_linear, and at 30 minutes to link back to D1. Do not use the 30-minute point for mechanism fits unless calibration placed it inside t_linear.

Order of addition, pre-specified: for the primary comparison, add compound last to a complete reaction, matching a typical screen. In a separate, labeled arm, preincubate compound with enzyme before substrate, and compound with substrate before enzyme, for a calibrated interval long enough that a slow-onset or substrate-depletion process would appear in the pilot (choose the interval by extending preincubation until any change in subsequent rate plateaus or until enzyme stability without compound fails, whichever comes first).

### 5. Measurements, in required order

Module A — optical and fluorophore, no enzymes. In assay buffer, measure the compound absorbance spectrum across the excitation and emission bands at the path length of the assay. Measure fluorescence of an in-range fluorophore spike plus compound, and compound alone (autofluorescence). Repeat after dilution of compound and after centrifugation or filtration if turbidity is suspected. This module estimates transmission and quenching.

Module B — reporter only. Omit the target. Supply the reporter’s substrate, which is the target’s product, at a concentration chosen from the reporter Km calibration (include a value near Km and one near the amount of intermediate expected in the original assay; determine that expected amount from a no-compound target progress curve using the orthogonal method in Module C, not from the fluorescence endpoint alone). Read initial rate with and without compound. Apply the Module A attenuation factor before comparing rates. A parallel arm with heat-inactivated reporter estimates non-enzymatic fluorescence drift.

Module C — target product, orthogonal to fluorescence. Run purified target plus its substrate with and without compound. Quantify product by a non-fluorescence method whose standard curve has been built from authentic product or from enzymatically generated product that was cross-checked by substrate disappearance. If LC or a calibrated chromatographic method is available, use it. If no orthogonal analytical method can be qualified, record that limit and do not claim target inhibition. Optionally also run the coupled fluorescence assay in parallel on the same mixes so optical correction can be compared with the orthogonal rate.

Module D — substrate competition, only if Module C shows a target-rate decrease that survives the reporter and optical accounting. Measure target initial rates across a substrate series centered on the calibrated Km (suggest a geometric series from well below Km to as high as solubility and the linear-rate window allow; the exact grid is set in the pilot so that Km and Vmax are identifiable, not copied from a paper). Hold inhibitor at two or more fixed soluble concentrations plus vehicle. Use the orthogonal readout as primary. A fluorescence readout is secondary and only after Module A correction and only if Module B showed no reporter inhibition. Separately, preincubate compound with substrate in the absence of enzyme, then start the reaction by enzyme addition or measure substrate remaining; this arm tests chemical substrate loss rather than competitive binding.

### 6. Controls

Required on every day: vehicle; no substrate; no enzyme; fluorophore spike; intermediate spike; compound-only optical blank; both enzymes’ activity checks. Heat-inactivated enzyme is a control only after the kill step is calibrated. Do not add an unlisted “known inhibitor” as a positive control unless that inhibitor has been qualified independently against these lots; absence of a reference inhibitor does not block the omission and orthogonal controls. A detergent or dilution anti-aggregation arm is a troubleshooting control, not a primary mechanism arm: use it only if Module A or rate losses suggest colloids, and pre-specify the detergent concentration by a pilot that shows the detergent itself does not change the uninhibited rate beyond tolerance.

### 7. Analysis

Correct fluorescence with the empirical Module A factor before any enzymatic comparison. Compare initial rates, not raw 30-minute endpoints. Report effects as ratios to vehicle with confidence intervals, using the independent mixture as the unit and day as a block.

Primary calls, applied in order:

- Optical contribution: predicted fluorescence loss from the enzyme-free spike versus observed coupled loss at the same concentration.
- Reporter contribution: Module B initial-rate ratio after optical correction.
- Target contribution: Module C initial-rate ratio.
- Among target contributions, compare nested nonlinear models of competitive, noncompetitive/mixed, and uncompetitive inhibition by extra-sum-of-squares or information criterion locked in advance. Competitive support requires an increase in apparent Km without a decrease in Vmax, and inhibition that weakens as substrate increases. Noncompetitive support is a Vmax drop with little Km change and IC50 insensitive to substrate. Uncompetitive support is inhibition that strengthens as substrate increases. Substrate destruction is supported if substrate preincubation without enzyme removes substrate or produces inhibition that is not relieved by fresh enzyme and that scales with preincubation time rather than with catalytic turnover.

Do not interpret a single IC50 at one substrate concentration as evidence for or against competition (D1).

### 8. Acceptance and stopping criteria

Pre-specify an equivalence margin for “no meaningful effect” (recommend 10% rate change, replaced by the pilot if instrument noise is larger; the margin must be wider than the 95% CI half-width achievable at the chosen n).

- Call optical interference sufficient only if the enzyme-free attenuation accounts for the coupled signal loss within that margin, Module B is equivalent to vehicle after correction, and Module C is equivalent to vehicle.
- Call reporter interference if Module B remains inhibited after optical correction beyond the margin, and Module C is equivalent to vehicle.
- Call target inhibition if Module C rate decreases beyond the margin while Module B, after optical correction, does not. Then, and only then, use Module D to accept or reject substrate competition against the other kinetic models.
- Call mixed mechanism if more than one module exceeds the margin. Report fractional contributions; do not force a single label.
- Stop the optical quantification early only if A at excitation and emission is within blank across the soluble range and the fluorophore spike is equivalent to vehicle; then continue enzyme modules.
- Stop mechanism claims if the compound is not soluble at the concentration that produced the original loss, or if day’s enzyme activity or blanks fail QC. Fix solubility or reagents and repeat; do not impute the missing rates.
- Do not stop after a positive target call before Module B and A are complete. On-target activity does not rule out a concurrent artifact.

### 9. Troubleshooting

If fluorescence falls but orthogonal product does not, stay with optical or reporter explanations; do not add target-binding experiments to override Module C. If orthogonal product falls and fluorescence falls more, subtract the optical and reporter fractions before estimating potency. If rates are nonlinear before the first planned sample, shorten the window and lower enzyme concentration; recalibrate t_linear. If coupler titration never plateaus, the reporter is rate-limiting or unstable; do not use coupled rates for Mode D. If inhibition increases with preincubation on enzyme but not on substrate, flag slow-onset or inactivation and add a jump-dilution arm: preincubate at high compound and enzyme, dilute into excess substrate, and compare the recovered rate with a matched control that was never preincubated. If inhibition vanishes after centrifugation or filtration of the compound, prioritize aggregation/scatter over stoichiometric binding. If compound autofluorescence rises while assay fluorescence falls, the net signal is confounded; rely on Module C.

## Limits

This design identifies which stage of the coupled chain is affected under the calibrated conditions. It does not by itself give a cellular potency, a selectivity panel, or a structural binding mode. Plate-reader geometry can make cuvette inner-filter formulas wrong; that is why the empirical spike is primary. A single enzyme lot cannot exclude lot-specific contaminants. Very tight-binding inhibitors can make Vmax appear to fall in a competitive system if enzyme concentration is not varied; if Module D is ambiguous, titrate target enzyme at fixed substrate and compound and look for a stoichiometric shift. IC50 versus enzyme concentration is a proposed resolving experiment, with the enzyme range chosen so free inhibitor and total inhibitor are distinguishable in the pilot. Failure to qualify an orthogonal product assay leaves target inhibition unproven regardless of how clean the fluorescence curve looks.
